|Posted date||Jun 20, 2013|
|International application number||2012JP063213|
|International publication number||WO 2012/165262|
|Date of international filing||May 23, 2012|
|Date of international publication||Dec 6, 2012|
The purpose of the present invention is to provide a novel compound which is effective for the treatment of hematological cancers, particularly multiple myeloma, and is also effective for the inhibition of an SP cell (side population cell) that causes the recurrence of cancers. This compound is a novel compound having a specific benzylamine structure.
|IPC(International Patent Classification)||
Contact Information for " BENZYLAMINE DERIVATIVE "
- The University of Tokushima Department of Industry-Academia Collaboration Research Planning, Intellectual Property Office
- URL: https://www.tokushima-u.ac.jp/ccr/
- Address: 2-1, Minamijosanjima-cho, Tokushima-city, Tokushima , 770-8506
- Phone: 81-88-656-7592
- Fax: 81-88-656-7593